Best Practices for the Development of PSC-Based Therapies: An Updated Draft

Program Description: This webinar will highlight the ISSCR’s "Best Practices for the Translation of PSC-Based Therapies." This resource is being developed for both academics and industry professionals. It outlines key concepts and principles in a visual format that can be applied globally, serving as an international framework for the development of PSC-based therapies.  

Webinar attendees will gain an overview of this “roadmap,” which includes sections on starting materials; banking; raw/ancillary materials, devices, and equipment; regulatory considerations; drug substance/drug product; preclinical development; and clinical research.  

Organizers:
- Kapil Bharti, PhD, Boston Children's Hospital/Harvard Medical School, USA
- Jacqueline Barry, PhD, Cell and Gene Therapy Catapult, UK

Presenters:
- Ricardo Baptista, PhD, SmartCella, Sweden
- Derek Hei, PhD, Kenai Therapeutics, USA
- Claire Henchcliffe, MD, DPhil, University of California, Irvine, USA
- Deborah Hursh, PhD, Hursh Cell Therapy Consulting, LLC, USA
- Jung-Hyun Kim, PhD, Ajou University, South Korea
- Jeanne Loring, PhD, Aspen Neuroscience, USA
- Tenneille Ludwig, PhD, WiCell Research Institute, USA

Aired 29 April 2025

Thank you to Our Sponsor

 
 

Previous
Previous

Modeling Human Neural Development and Disease with iPSCs

Next
Next

ISSCR Embryo Models Working Group: Summary of Findings and Recommendations